Preclinical imaging (In-VIVO) is used in live animal research for drug development. Preclinical imaging is further used to monitor the treatment response for early indications of efficacy. The technological development of in vivo imaging provides an opportunity for studying disease at the molecular level in a quantitative way.
Read Report Overview -
https://www.transparencymarketresearch.com/preclinical-imaging-market.html
In vivo imaging acts as a bridge between in vitro exploratory and in vivo clinical research which facilitates the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key disease areas targeted with in vivo preclinical imaging are cancers, autoimmune diseases, neurological disorders, and cardiovascular diseases. Use of preclinical imaging in cancer is about 70% which is followed by autoimmune diseases and neurological disorders which accounts for 36% and 32%, respectively.
Factors such as technological advancements, and growth in prevalence of chronic disease such as cancer, cardiovascular, rheumatoid arthritis, and neurological disorders are driving the preclinical imaging market globally. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17846
Technological development such as “Aspect’s M2,” a preclinical imaging product developed by Aspect imaging, is used for drug development but without the cost, complexity, and technical burden of traditional MRI systems. Other factors such as growing demand for non-invasive imaging techniques and government funding for research and development activities are estimated to fuel the preclinical imaging market. However, the growth of the preclinical imaging market is hindered by some factors such as high product price that decreases the adoption rates in academic institutions and limited number of application of each modality, discouraging the sale of products.
The preclinical imaging (In-VIVO) market has been segmented by product, application, end-user, and geography. In terms of product, the preclinical imaging market is sub-divided into imaging modalities and reagents. The imaging modalities segment is classified into single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), micro computed tomography (microCT), positron emission tomography (PET), optical imaging, and magnetic particle imaging (MPI). MRI and PET are highly used in preclinical imaging. Sometimes, combination of imaging techniques are used for good quality results such as combination of PET and CT.
Request for Analysis of COVID-19 Impact on Preclinical Imaging (In-VIVO) Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=17846
The reagents segment is classified into fluorescent imaging reagents, bioluminescent imaging reagents, PET radioactive tracers, MRI contrasting reagents, X-ray CT contrasting reagents, and ultrasound contrasting reagents. In terms of application, the preclinical imaging market is classified into research and development and drug discovery. In terms of end-user, the market is classified into pharmaceutical companies, biotech companies, and research institutes. Geographically, the preclinical imaging market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Geographically, North America dominates the preclinical imaging market due to rapid adoption of several type of modalities by end-user, technological advancement, growth in prevalence of chronic diseases such as cancer, cardiovascular disease, and others. According to the National Cancer Institute, about 1,685,210 new cases of cancer are likely to be diagnosed in the U.S. and 595,690 people are estimated to die from the disease by 2016 end.
The North America market is followed by Europe and Asia Pacific. Europe is the second largest market for preclinical imaging due to growing health care awareness among people and increasing number of research and development activities. Asia Pacific is expected to grow at a higher rate due to rise in number of population, increase in opportunity for clinical and preclinical studies in low cost, and government support for research and development activities.
Pre Book Preclinical Imaging (In-VIVO) Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=17846<ype=S
Major players operating in this market include Bruker Corporation, MR Solutions, PerkinElmer Inc., TriFoil Imaging, FUJIFILM Holdings America Corporation, Mediso Ltd., Miltenyi Biotec, Aspect Imaging, and MILabs B.V.
More Trending Reports by Transparency Market Research –
Forensic Technologies Market:
Remote Patient Monitoring Devices Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
The report provides a detailed analysis of the In vivo CRO market, including regulatory policies, upcoming technologies, key market trends, industry drivers, challenges, and key players’ profiles and strategies.
All industries have been severely affected by the virus, and this report assesses the market, keeping in mind the presence of the pandemic.To avail Copy of the Global In vivo CRO Sample Report, Click @ https://www.reportsanddata.com/sample-enquiry-form/1634If you are involved in the In vivo CRO industry or intend to be, then this study will provide you a comprehensive outlook.
Key players who influence the In vivo CRO market:River Laboratories, Chiltern International Ltd., Parexel International, Pharmaceutical Product Development, LLC (PPD) and PRA Health SciencesFor the purpose of the study, this Reports and Data have segmented the Global In vivo CRO Market on the basis of type, GLP type, indication and the regional outlook:Type Rodent-BasedRatsMiceOthersNon-Rodent BasedHamstersGuinea PigsOthersGLP TypeNon-GLPIn HouseOutsourcingGLP ToxicologyIn HouseOutsourcingIndication Autoimmune/Inflammatory ConditionsRheumatoid ArthritisMultiple SclerosisOsteoarthritisIrritable Bowel SyndromeOthersPain ManagementChronic PainAcute PainOncologyBlood CancerSolid TumorSyngeneic ModelPatient Derived XenograftXenograftOthersCNS conditionsEpilepsyParkinson’s DiseaseHuntington’s DiseaseStrokeTraumatic Brain InjuryALSMuscle RegenerationOthersDiabetesObesityOthersBased on region, the In vivo CRO global industry is segmented into:North AmericaEuropeGermanyAsia PacificLatin AmericaMiddle East and AfricaGrab Your Report at an Impressive Discount!
Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/1634The insights that are offered by this report of the In vivo CRO market are: – Detailed Overview of Global In vivo CRO market helps deliver clients and businesses making strategies.
– SWOT Analysis of each key players mentioned along with its company profile with the help of Porter’s five forces tool mechanism to compliment the same.Key Questioned Answered mentioned in the Report - What are the products offered by the In vivo CRO industry presently?What are the different applications of the products offered in this market of In vivo CRO?Who could be claimed as the most dominant and influential players in this global industry?Which factors act as the drivers of this market, and which factors pull this industry down acting as restraints?What can be determined by the trends obtained from the evaluation of the historical data for the In vivo CRO industry?There are 15 Chapters to display the Global In vivo CRO market.
Chapter 1 About Executive Summary to describe Definition, Specifications, and Classification of In vivo CRO market, Applications [Industrial & Commercial], Market Segment by Regions; Chapter 2 analyzes the objective of the study.
In Vivo (Preclinical) Imaging Market Research Report: By Application (Nuclear Imaging, Optical Imaging), By Techniques (Radioisotopes, Biomarkers, And Luminescent Proteins Based), And By End Users (Hospitals & Clinics, Imaging Centers, Research Organizations)- Global Forecast Till 2023 The report presents a detailed analysis of the global In Vivo (Preclinical) Imaging Market by providing readers with a comprehensive overview of the market’s historical trajectory.
The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.
The In Vivo (Preclinical) Imaging Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.
Market Segmentation: The global in vivo imaging market has been segmented on the basis of applications, techniques, and end users.Based on the applications, the market has been segmented into nuclear imaging, optical imaging, and others.Based on the techniques, the market has been segmented as radioisotopes based, biomarkers based, luminescent proteins based technique, and others.
Based on the end users, the market has been segmented as hospitals & clinics, imaging centers, research organizations, and others.
For Market In Vivo (Preclinical) Imaging Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply.
